By Adriano Marchese 

Koninklijke Philips NV said Tuesday that it has received emergency use authorization for its patient monitors and active displays during the pandemic from the U.S. Food and Drug Administration.

The technology company said the emergency use authorization will be for its IntelliVue Patient Monitors MX750 and MX850 as well as its IntelliVue Active Displays AD75 and AD85.

Philips said that the emergency use authorization allows the company to begin delivering the new remote patient-monitoring product to hospitals in the U.S.

The company added that it is "significantly increasing" its patient-monitor production to address the demand for more intensive-care-unit capacity.


Write to Adriano Marchese at


(END) Dow Jones Newswires

June 02, 2020 08:34 ET (12:34 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.